University Hospital Tuebingen
Tübingen, 72076, Germany
NCT Number: NCT03004066
10 patients with chronic heart failure receiving daptomycin therapy after implantation of a left ventricular heart assist system. Measurement of daptomycin levels in drainage fluids (mediastinal and pleural drainage systems) and in blood samples.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Observational
Tübingen, 72076, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
standard care
Time frame: 4 days
Pharmacokinetics of Daptomycin in intensive care patients with wound drainage after surgery (LVAD implantation)
Time frame: 4 days
Pharmacokinetics of Daptomycin in intensive care patients after surgery (LVAD implantation)
Time frame: 14 days
incidence of gram-positive infections
University Hospital Tuebingen
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05408104
Cardiovascular Diseases, Heart Assist Device
Chicago, Illinois, United States
View Trial Details